Access to this symposium requires KEY ZONE access (paid
registration) to HDCN. For information about subscribing to HDCN,
please go to this link.
|
Bone in ESRD: Abnormal Bone Turnover or Bone Mass or Both? |
Dunstan C. |
Osteoprotegerin/RANK Ligand: The
Final Link? |
|
|
Mundy G. |
Bisphosphonates and Statins:The
Mevalonate Pathway in Bone |
|
|
Price P. |
The Cardiovascular-Bone Link |
|
|
New Insights into Immunosuppressive Therapy |
Vincenti F. |
Tolerance Induction Protocols |
|
|
Gaston R. |
The High Risk Recipient: An Overview |
|
|
Knechtle S. |
Immunosuppressive Therapy
for the High Risk Recipient |
|
|
Harmon W. |
Immunosuppression in Pediatric Patients:
Ideal Candidates for Minimization |
|
|
Visit us next week for new topics !
|
Audio
tapes from this Symposia can be purchased from:

|